Rehinged combines retrospective Medicare utilization, provider and practice context, current enrichment where available, and your product criteria to model the prescriber market, rank commercial fit and turn the answer into rep-ready work.
Two prescribers with the same specialty can have very different documented procedure patterns, practice settings and commercial relevance.
Scores are illustrative outputs of a product-specific commercial-fit model — not procedure counts.
There is no universal “best prescriber.” There is only fit for what you sell.
Rehinged treats each evidence class according to what it can actually prove. Historical utilization establishes documented behavior. Current context has to come from current sources, enrichment and client knowledge.
Establishes documented historical procedure and service behavior. It is useful evidence of market fit, not a claim about what the prescriber is doing today.
Establishes provider identity, specialty, location and practice context where the underlying source supports it.
Adds current organizational, web and commercial context where reliable sources are available.
Adds current customers, product criteria, territory knowledge, sales feedback and first-party commercial learning.
Retrospective Medicare utilization can show documented historical activity in the procedure or service family relevant to what you sell.
The surrounding utilization pattern can distinguish a true product fit from a provider who simply shares the right specialty label.
Specialty and subspecialty establish useful clinical context, but they are not the commercial answer by themselves.
Practice structure and organizational affiliation can change buyer logic, access and how a commercial team should approach the account.
Current enrichment can add organizational and commercial context where reliable sources support it.
What you sell determines which utilization, specialties, settings and commercial attributes matter most to the model.
Every published score carries its source and date. Retrospective evidence is labeled retrospective. Where evidence is weak, we say so.
The work doesn’t disappear into a folder. It lands in a Rehinged Intelligence account that keeps your market — and the next piece of work starts from it.
Most Market Drafts are live within 1–2 business days. We’ll tell you if yours takes longer.
Once your Full Build is complete, we can scope additional commercial work against the market we’ve built together. See the finished work →
Finish the sentence. We’ll build the first read on your prescriber market. The Market Draft is free.
The job is not to confirm your prescriber thesis — it is to determine whether the market supports it. Where the evidence is weak, we say so. What you tell us about your company stays yours — governed by our privacy terms, never sold, and never used to build another client’s market.
FREE · NO CARD · NO MANDATORY CALL · NOBODY CALLS YOU UNLESS YOU ASK